150 related articles for article (PubMed ID: 31666248)
1. Understanding the Right to Try Act.
Agarwal R; Saltz LB
Clin Cancer Res; 2020 Jan; 26(2):340-343. PubMed ID: 31666248
[TBL] [Abstract][Full Text] [Related]
2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
3. Oncologists' reflections on patient rights and access to compassionate use drugs: A qualitative interview study from an academic cancer center.
Stout J; Smith C; Buckner J; Adjei AA; Wentworth M; Tilburt JC; Master Z
PLoS One; 2021; 16(12):e0261478. PubMed ID: 34919568
[TBL] [Abstract][Full Text] [Related]
4. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
[TBL] [Abstract][Full Text] [Related]
5. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
Puthumana J; Miller JE; Kim J; Ross JS
JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
[TBL] [Abstract][Full Text] [Related]
6. Patient advocacy organizations' information for patients on pre-approval access to investigational treatments.
Folkers KM; Leone S; Caplan A
BMC Res Notes; 2019 Oct; 12(1):706. PubMed ID: 31661023
[TBL] [Abstract][Full Text] [Related]
7. Providing Patients with Critical or Life-Threatening Illnesses Access to Experimental Drug Therapy: A Guide to Clinical Trials and the US FDA Expanded Access Program.
Speers MA
Pharmaceut Med; 2019 Apr; 33(2):89-98. PubMed ID: 31933253
[TBL] [Abstract][Full Text] [Related]
8. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
9. Single-patient expanded access: A primer for pharmacists.
Smith AJF; Redic KA
Am J Health Syst Pharm; 2022 Nov; 79(23):2118-2127. PubMed ID: 36056791
[TBL] [Abstract][Full Text] [Related]
10. Right to try?
Lieu CH; Sorkin A; Messersmith WA
J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
[No Abstract] [Full Text] [Related]
11. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
Bateman-House A; Robertson CT
JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
[No Abstract] [Full Text] [Related]
12. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
Chapman CR; Eckman J; Bateman-House AS
Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
[TBL] [Abstract][Full Text] [Related]
13. Promoting Patient Interests in Implementing the Federal Right to Try Act.
Lynch HF; Zettler PJ; Sarpatwari A
JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
[No Abstract] [Full Text] [Related]
14. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
15. Experimental drugs on trial.
Benderly BL
Sci Am; 2007 Oct; 297(4):92-9. PubMed ID: 17926760
[No Abstract] [Full Text] [Related]
16. False hope with the Right to Try Act.
The Lancet
Lancet; 2018 Jun; 391(10137):2296. PubMed ID: 29900858
[No Abstract] [Full Text] [Related]
17. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
Hoerger M
Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
[TBL] [Abstract][Full Text] [Related]
18. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
19. Reconciling States' "Right to Try" Legislation and FDA's Expanded Access Program: Legal Issues.
Shapiro RS
Ther Innov Regul Sci; 2017 Mar; 51(2):153-156. PubMed ID: 30231723
[TBL] [Abstract][Full Text] [Related]
20. Access before approval--a right to take experimental drugs?
Okie S
N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
[No Abstract] [Full Text] [Related]
[Next] [New Search]